BioNeutra International, Ltd.
BIMO · OTC
4/30/2023 | 1/31/2023 | 10/31/2022 | 7/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 18.4% | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 99.5% | 99.4% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -49.1% | -111.6% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -5.7% | -89.5% | – | – |
| EPS Diluted | -0 | -0 | -0 | -0 |
| % Growth | 91.4% | 50% | 0% | – |
| Operating Cash Flow | -$0 | $0 | – | – |
| Capital Expenditures | $0 | $0 | – | – |
| Free Cash Flow | -$0 | $0 | – | – |